Results 181 to 190 of about 14,397,534 (393)

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Effects of dupilumab treatment on patch test reactions: A retrospective evaluation. [PDF]

Clin Exp Allergy, 2021
de Wijs LEM, van der Waa JD, Nijsten T, Silverberg JI, Kunkeler ACM, Hijnen DJ.   +5 more
europepmc   +1 more source

Quantitative and 3/dimensional analysis of Langerhans' cells following occlusion with patch tests using confocal laser scanning microscopy.

, 1993
Axel Emilson, Magnus Lindberg, B Forslind, Annika Scheynius   +3 more
openalex   +2 more sources

Exacerbation of allergic contact dermatitis from amcinonide triggered by patch testing [PDF]

, 2001
Denis Sasseville
openalex   +1 more source

A bioinformatics screen identifies TCF19 as an aggressiveness‐sustaining gene in prostate cancer

Molecular Oncology, EarlyView.
Gene expression meta‐analysis in multiple prostate cancer patient cohorts identifies Transcription factor 19 (TCF19) as an aggressiveness‐sustaining gene with prognostic potential. TCF19 is a gene repressed by androgen signaling that sustains core cancer‐related processes such as vascular permeability or tumor growth and metastasis.
Amaia Ercilla, Jana R. Crespo, Saioa Garcia‐Longarte, Marta Fidalgo, Sara del Palacio, Natalia Martin‐Martin, Onintza Carlevaris, Ianire Astobiza, Sonia Fernández‐Ruiz, Marc Guiu, Laura Bárcena, Isabel Mendizabal, Ana M. Aransay, Mariona Graupera, Roger R. Gomis, Arkaitz Carracedo   +15 more
wiley   +1 more source

Atopy patch test

Indian Journal of Dermatology, Venereology and Leprology, 2019
Abhishek De, Sandipan Dhar, Varsha Vaidyanathan, Aarti Sarda   +3 more
openaire   +2 more sources

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Factors Influencing Patients’ Awareness of the Benefits of Patch Testing: A Questionnaire Survey

Siriraj Medical Journal, 2017
Background: Patch testing is a well-established method of diagnosing contact dermatitis; although it is a complex and time consuming process. Objective: To determine the factors influencing patients’ awareness of the benefit of patch testing by using a ...
Waranya Boonchai, Rasthawathana Desomchoke, Pacharee Iamtharachai, Daranee Sornmek   +3 more
doaj  

Recurrent Acute Generalized Exanthematous Pustulosis to Two Different Drugs: Oxacillin and Dextromethorphan Confirmed by Patch Test. [PDF]

Dermatol Pract Concept, 2022
Kenani Z, Gammoudi R, Fathallah N, Aounallah A, Mokni S, Boussofara L, Ghariani N, Belajouza C, Ben Salem C, Denguezli M.   +9 more
europepmc   +1 more source

P204 Patch test on eight fiber-glass reinforced plastics factory workes with history of skin problems

, 1999
Keiko Minamoto
openalex   +2 more sources